The US FDA has requested medical device makers to submit plans to monitor and patch post-market cybersecurity vulnerabilities, create a process for secure design and development of devices, and provide a software bill of materials. This comes as the FDA’s grace period ends on October 1, allowing it to reject devices that lack necessary cybersecurity controls. The move aims to mitigate mounting cyber threats that could disrupt healthcare delivery and pose a national security concern.
From Risk Scoring to Dynamic Policy Enforcement Without Network Redesign
Healthcare organizations are facing increasing cybersecurity challenges as cybercriminals target devices that deliver patient care. A solution integrating Armis Centrix™ and Elisity’s microsegmentation platform helps
